Drug Trial Radar · NCT07532603
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
342
Planned (sponsor's estimate)
Start
Mar 19, 2026
Primary completion
Dec 31, 2028
Study completion Jul 31, 2029
Sponsor
- Lead sponsor
- Priovant Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Conditions
- Lichen Planopilaris
Interventions
Oral BrepocitinibDrug
Oral
PlaceboDrug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants achieving IGA score 0/1 and ≥ 2-step reduction from baseline at Week 24Time frame: Week 24
Locations
61 sites in 4 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Birmingham, Alabama · Recruiting
Clinical Trial Site
Phoenix, Arizona · Recruiting
Clinical Trial Site
Scottsdale, Arizona · Recruiting
Clinical Trial Site
Irvine, California · Recruiting
Clinical Trial Site
Oakland, California · Recruiting
Clinical Trial Site
Sacramento, California · Recruiting
Clinical Trial Site
San Francisco, California · Recruiting
Clinical Trial Site
Denver, Colorado · Recruiting
Clinical Trial Site
Farmington, Connecticut · Recruiting
Clinical Trial Site
New Haven, Connecticut · Recruiting
Clinical Trial Site
Miami, Florida · Recruiting
Clinical Trial Site
Chicago, Illinois · Recruiting
Clinical Trial Site
Skokie, Illinois · Recruiting
Clinical Trial Site
Clarksville, Indiana · Recruiting
Clinical Trial Site
Indianapolis, Indiana · Recruiting
Clinical Trial Site
Leawood, Kansas · Recruiting
Clinical Trial Site
Louisville, Kentucky · Recruiting
Clinical Trial Site
Boston, Massachusetts · Recruiting
Clinical Trial Site
Burlington, Massachusetts · Recruiting
Clinical Trial Site
Ann Arbor, Michigan · Recruiting
Clinical Trial Site
Ann Arbor, Michigan · Recruiting
Clinical Trial Site
Medina, Minnesota · Recruiting
Clinical Trial Site
Minneapolis, Minnesota · Recruiting
Clinical Trial Site
Kansas City, Missouri · Recruiting
Clinical Trial Site
Lee's Summit, Missouri · Recruiting
Clinical Trial Site
Lebanon, New Hampshire · Recruiting
Clinical Trial Site
New Hyde Park, New York · Recruiting
Clinical Trial Site
New York, New York · Recruiting
Clinical Trial Site
Durham, North Carolina · Recruiting
Clinical Trial Site
Cleveland, Ohio · Recruiting
Clinical Trial Site
Columbus, Ohio · Recruiting
Clinical Trial Site
Medina, Ohio · Recruiting
Clinical Trial Site
Portland, Oregon · Recruiting
Clinical Trial Site
Philadelphia, Pennsylvania · Recruiting
Clinical Trial Site
Charleston, South Carolina · Recruiting
Clinical Trial Site
Murfreesboro, Tennessee · Recruiting
Clinical Trial Site
Smyrna, Tennessee · Recruiting
Clinical Trial Site
Austin, Texas · Recruiting
Clinical Trial Site
Austin, Texas · Recruiting
Clinical Trial Site
Cedar Park, Texas · Recruiting
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.